These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11391343)

  • 21. [Measles antibodies concentration in vaccinated children and adolescents with autoimmune hepatitis].
    Szenborn L; Kacprzak-Bergman I; Zaleska I; Gruszka J
    Pol Merkur Lekarski; 2004 Oct; 17(100):326-30. PubMed ID: 15690693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Young children non-immunized against measles: characteristics and programmatic implications.
    Chowdhury F; Khan AI; Hossain MI; Malek MA; Faruque AS; Ahmed T; Salam MA
    Acta Paediatr; 2006 Jan; 95(1):44-9. PubMed ID: 16373295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants.
    Gatchalian S; Yao Y; Zhou B; Zhang L; Yoksan S; Kelly K; Neuzil KM; Yaïch M; Jacobson J
    Vaccine; 2008 Apr; 26(18):2234-41. PubMed ID: 18394765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody response after measles immunization.
    Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Passive acquired immunity against measles in infants born to naturally infected and vaccinated mothers.
    Szenborn L; Tischer A; Pejcz J; Rudkowski Z; Wójcik M
    Med Sci Monit; 2003 Dec; 9(12):CR541-6. PubMed ID: 14646978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular and humoral immune responses to measles in immune adults re-immunized with measles vaccine.
    Wong-Chew RM; Beeler JA; Audet S; Santos JI
    J Med Virol; 2003 Jun; 70(2):276-80. PubMed ID: 12696117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of measles antibody in children of different ages in Shiraz, Islamic Republic of Iran.
    Karimi A; Arjomandi A; Alborzi A; Rasouli M; Kadivar MR; Obood B; Pourabbas B
    East Mediterr Health J; 2004; 10(4-5):468-73. PubMed ID: 16335636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoglobulin prophylaxis of measles in acute lymphoblastic leukaemia.
    Kay HE; Rankin A
    Lancet; 1984 Apr; 1(8382):901-2. PubMed ID: 6143200
    [No Abstract]   [Full Text] [Related]  

  • 30. [Post-exposure prophylaxis against measles].
    Følsgaard NV; Nygaard U; Christiansen CB; Harder KM; Andersen PH; Poulsen A
    Ugeskr Laeger; 2015 Nov; 177(48):V06150467. PubMed ID: 26617173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
    Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ
    J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment.
    LeBaron CW; Beeler J; Sullivan BJ; Forghani B; Bi D; Beck C; Audet S; Gargiullo P
    Arch Pediatr Adolesc Med; 2007 Mar; 161(3):294-301. PubMed ID: 17339511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rabies postexposure management of travelers presenting to travel health clinics in Auckland and Hamilton, New Zealand.
    Shaw MT; O'Brien B; Leggat PA
    J Travel Med; 2009; 16(1):13-7. PubMed ID: 19192122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda.
    Mupere E; Karamagi C; Zirembuzi G; Grabowsky M; de Swart RL; Nanyunja M; Mayanja H
    Vaccine; 2006 May; 24(19):4111-5. PubMed ID: 16554111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy.
    Aurpibul L; Puthanakit T; Sirisanthana T; Sirisanthana V
    Clin Infect Dis; 2007 Sep; 45(5):637-42. PubMed ID: 17683001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serosurvey of measles, mumps and rubella antibodies in Saudi children.
    Al-Mazrou YY; Khalil MK; Tischer A; Al-Jeffri MH; Al-Ghamdi YS; Bakhsh MM; Mishkas AA; Elgizouli SA
    Saudi Med J; 2005 Oct; 26(10):1551-4. PubMed ID: 16228054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of protective antibody against measles in HIV-infected children with immune recovery after highly active antiretroviral therapy.
    Aurpibul L; Puthanakit T; Siriaksorn S; Sirisanthana T; Sirisanthana V
    HIV Med; 2006 Oct; 7(7):467-70. PubMed ID: 16925733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of antibody titres after measles vaccination: fever within 7 days of vaccination and efficacy of booster doses.
    Egami T; Egami K; Tanoue A
    Arch Dis Child; 2008 Apr; 93(4):319-20. PubMed ID: 17488762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.